Anthracycline & Cyclophosphamide treatment scheme

DRUG2 trials

Sponsors

University of Sao Paulo General Hospital, Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Conditions

Breast CancerBreast Cancer Early Stage Breast Cancer (Stage 1-3)CardiotoxicityCardiovascular DiseaseEndothelial DisfunctionHR Positive/HER2 Low Breast CancerNeurovascular Disorder

Phase 2

Chemotherapy With or Without Adebrelimab and T-DXh as Neoadjuvant Therapy for HR+/HER2 Low Early Stage Breast Cancer

Not yet recruitingNCT07317778

Cancer Institute and Hospital, Chinese Academy of Medical SciencesBreast Cancer Early Stage Breast Cancer (Stage 1-3), HR Positive/HER2 Low Breast Cancer

Start: 2026-02-15End: 2033-09-15Target: 249Updated: 2026-01-05

Unknown Phase

Effect of Anthracyclines and Cyclophosphamide on Cardiovascular Responses

CompletedNCT04568161

University of Sao Paulo General HospitalBreast Cancer, Cardiotoxicity, Cardiovascular Disease +2

Start: 2020-08-03End: 2025-03-03Updated: 2025-04-03